RA Capital — 2026 Investments
7 investments dated 2026 · listed companies and verified rows first · show all
Stipple Bio develops targeted oncology therapies that act on tumor-specific cell surface epitopes to expand druggable targets and improve therapeutic index for cancer patients.
BiotechHealthtechCambridge, US
Aaron Ring(Co-founder)Aashish Manglik(Co-founder)Jeff Landau(Chief Executive Officer)Roland Gendron(Chief Business Officer)Michelle Zhang(Chief Scientific Officer)
BoardVineeta Agarwala(Director)
Board seatDerek DiRocco· per SEC Form D
BiotechBoston, US
William Daley Bonificio(Executive Officer, Promoter)Stephen Basil Thomas(Executive Officer, Director, Promoter)Naveen Manu Daryani(Executive Officer)
BoardGianna Hoffman-Luca(Director)
Board seatAndrew Levin· per SEC Form D · $45M raise · filed Feb 2026
Privately-held biotech company developing biologic therapies for retinal diseases
BiotechBoston, US
William Daley Bonificio(Executive Officer, Promoter)Megan Krench(Director)Stephen Basil Thomas(Executive Officer, Promoter)Naveen Manu Daryani(Executive Officer, Director, Promoter)Vishal Kapoor(Director)
Board seatZach Scheiner· per SEC Form D
BiotechBoston, US
CAROLINE LOEW(Executive Officer, Director, Promoter)David Feltquate(Executive Officer)Maiken Keson-Brookes(Executive Officer)
BoardJULIE GRANT(Director)
Board seatEmily MinkowAndrew Levin· per SEC Form D · $298.4M raise · filed Mar 2026
BiotechCharlottesville, US
Kevin S Eisenfrats(Executive Officer, Director, Promoter)Iris Van Alderwerelt van Rosenburgh(Director)Martin J Emerson(Director)Tom Thorpe(Director)Michael King(Director)
BoardGurdane Bhutani(Director)
PartnerLaura Stoppel· quoted
BiotechBoston, US
Sara Pacheco(Executive Officer)Neil Buckley(Executive Officer, Director)Gregory Frank Oakes(Executive Officer)
BoardTim Lohoff(Director)Cindy Xiong(Director)Andrew Levin(Director)
BiotechSouth San Francisco, US
Grace Lu(Executive Officer)James Christensen(Executive Officer, Director)Charles Baum(Executive Officer, Director)
BoardMichael Goller(Director)Reid Huber(Director)Peter Thompson(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.